|Articles|July 20, 2022
mRNA 5’ cap characterization using LC-HRAM-MS
Author(s)Thermo Fisher Scientific
The 5’ capping is a CQA for mRNA vaccines and therapeutics, and needs to be fully characterized. Learn a sensitive, robust LC-HRAM-MS/MS method for identification and quantitation of 5’ cap.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
Why AI-Native Cell Manufacturing Is the Future of Drug Discovery (Part 1)
2
New AI Oncology Alliance Highlights Industry Push for Scalable Genomics
3
Industry Outlook 2026: Biopharma Braces for Economic Upheaval While Eyeing AI-Driven Transformation (Part 1)
4
GSK Advances Vaccine Delivery and Hepatitis B Treatment
5